J&J’s Drug Pipeline Has Some Potential Blockbusters
Johnson & Johnson (JNJ) has a pipeline of new drugs including a nasal spray for depression and COVID-19 vaccine candidate.
Johnson & Johnson (JNJ) has a pipeline of new drugs including a nasal spray for depression and COVID-19 vaccine candidate.
Last qtr, JP Morgan’s (JPM) numbers were good (outside of -45% profit growth) and the stock is set up well for 2021.
Pepsico (PEP) had a poor qtr as the Coronavirus hurt beverage sales convenience stores and gas stations.
Business consulting firm Accenture (ACN) is performing admirably in this environment as its New Digital offerings shine.
Adobe (ADBE) is having a slowdown in its advertising cloud due to COVID-19, which might slow ADBE’s profit growth.
It seems like Costco (COST) should have booming profits due to COVID-19, but profit growth was just 0% last qtr.
Dollar General (DG) has been one of the top retailers in the nation during the Coronavirus pandemic. Expect it to continue.
Target (TGT) is transforming itself to thrive in a Coronavirus world, and the stock might benefit in a big way next year.
Fortinet (FTNT) is a “safer” cyber security stock that is making profits, buying back stock and is breaking out to new highs.
Ross Stores (ROST) is selling some of its inventory below-cost to get rid of it while its clothing stores slowly re-open.
TJX (TJX) is seeing strong demand at its re-opened TJ Maxx and Marshalls stores. But the company has issues to work through.
Nike’s (NKE) Digital sales soared 75% last qtr to account for 30% of sales. But the stock seems expensive with a 43 P/E.